164 related articles for article (PubMed ID: 1392135)
1. Recent developments in the biology of dystrophin and related molecules.
Karpati G
Curr Opin Neurol Neurosurg; 1992 Oct; 5(5):615-21. PubMed ID: 1392135
[TBL] [Abstract][Full Text] [Related]
2. Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies.
Matsumura K; Campbell KP
Muscle Nerve; 1994 Jan; 17(1):2-15. PubMed ID: 8264699
[TBL] [Abstract][Full Text] [Related]
3. Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy.
Araki E; Nakamura K; Nakao K; Kameya S; Kobayashi O; Nonaka I; Kobayashi T; Katsuki M
Biochem Biophys Res Commun; 1997 Sep; 238(2):492-7. PubMed ID: 9299538
[TBL] [Abstract][Full Text] [Related]
4. Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice.
Ito K; Kimura S; Ozasa S; Matsukura M; Ikezawa M; Yoshioka K; Ueno H; Suzuki M; Araki K; Yamamura K; Miwa T; Dickson G; Thomas GD; Miike T
Hum Mol Genet; 2006 Jul; 15(14):2266-75. PubMed ID: 16777842
[TBL] [Abstract][Full Text] [Related]
5. Deficiency of the 50K dystrophin-associated glycoprotein in severe childhood autosomal recessive muscular dystrophy.
Matsumura K; Tomé FM; Collin H; Azibi K; Chaouch M; Kaplan JC; Fardeau M; Campbell KP
Nature; 1992 Sep; 359(6393):320-2. PubMed ID: 1406935
[TBL] [Abstract][Full Text] [Related]
6. The effects of dystrophin gene mutations on the ERG in mice and humans.
Cibis GW; Fitzgerald KM; Harris DJ; Rothberg PG; Rupani M
Invest Ophthalmol Vis Sci; 1993 Dec; 34(13):3646-52. PubMed ID: 8258524
[TBL] [Abstract][Full Text] [Related]
7. Sarcoglycans in muscular dystrophy.
Hack AA; Groh ME; McNally EM
Microsc Res Tech; 2000 Feb 1-15; 48(3-4):167-80. PubMed ID: 10679964
[TBL] [Abstract][Full Text] [Related]
8. Dystrophin and muscular dystrophy: past, present, and future.
O'Brien KF; Kunkel LM
Mol Genet Metab; 2001; 74(1-2):75-88. PubMed ID: 11592805
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity.
Cox GA; Cole NM; Matsumura K; Phelps SF; Hauschka SD; Campbell KP; Faulkner JA; Chamberlain JS
Nature; 1993 Aug; 364(6439):725-9. PubMed ID: 8355788
[TBL] [Abstract][Full Text] [Related]
10. Dystrophin immunocytochemistry in muscle culture: detection of a carrier of Duchenne muscular dystrophy.
Miranda AF; Francke U; Bonilla E; Martucci G; Schmidt B; Salviati G; Rubin M
Am J Med Genet; 1989 Feb; 32(2):268-73. PubMed ID: 2648829
[TBL] [Abstract][Full Text] [Related]
11. Deficiency of dystrophin-associated proteins in Duchenne muscular dystrophy patients lacking COOH-terminal domains of dystrophin.
Matsumura K; Tomé FM; Ionasescu V; Ervasti JM; Anderson RD; Romero NB; Simon D; Récan D; Kaplan JC; Fardeau M
J Clin Invest; 1993 Aug; 92(2):866-71. PubMed ID: 8349821
[TBL] [Abstract][Full Text] [Related]
12. Functions of dystrophin and dystrophin associated proteins.
Michalak M; Opas M
Curr Opin Neurol; 1997 Oct; 10(5):436-42. PubMed ID: 9330892
[TBL] [Abstract][Full Text] [Related]
13. Dissecting the signaling and mechanical functions of the dystrophin-glycoprotein complex.
Judge LM; Haraguchiln M; Chamberlain JS
J Cell Sci; 2006 Apr; 119(Pt 8):1537-46. PubMed ID: 16569668
[TBL] [Abstract][Full Text] [Related]
14. The role of dystroglycan, a novel receptor of laminin and agrin, in cell differentiation.
Matsumura K; Yamada H; Saito F; Sunada Y; Shimizu T
Histol Histopathol; 1997 Jan; 12(1):195-203. PubMed ID: 9046055
[TBL] [Abstract][Full Text] [Related]
15. Effects of dystrophin isoforms on signal transduction through neural retina: genotype-phenotype analysis of duchenne muscular dystrophy mouse mutants.
Pillers DA; Weleber RG; Green DG; Rash SM; Dally GY; Howard PL; Powers MR; Hood DC; Chapman VM; Ray PN; Woodward WR
Mol Genet Metab; 1999 Feb; 66(2):100-10. PubMed ID: 10068512
[TBL] [Abstract][Full Text] [Related]
16. Genetic correction of dystrophin deficiency and skeletal muscle remodeling in adult MDX mouse via transplantation of retroviral producer cells.
Fassati A; Wells DJ; Sgro Serpente PA; Walsh FS; Brown SC; Strong PN; Dickson G
J Clin Invest; 1997 Aug; 100(3):620-8. PubMed ID: 9239410
[TBL] [Abstract][Full Text] [Related]
17. Current understanding of dystrophin-related muscular dystrophy and therapeutic challenges ahead.
Zhou GQ; Xie HQ; Zhang SZ; Yang ZM
Chin Med J (Engl); 2006 Aug; 119(16):1381-91. PubMed ID: 16934185
[TBL] [Abstract][Full Text] [Related]
18. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle.
Ervasti JM; Ohlendieck K; Kahl SD; Gaver MG; Campbell KP
Nature; 1990 May; 345(6273):315-9. PubMed ID: 2188135
[TBL] [Abstract][Full Text] [Related]
19. Redefinition of dystrophin isoform distribution in mouse tissue by RT-PCR implies role in nonmuscle manifestations of duchenne muscular dystrophy.
Tokarz SA; Duncan NM; Rash SM; Sadeghi A; Dewan AK; Pillers DA
Mol Genet Metab; 1998 Dec; 65(4):272-81. PubMed ID: 9889014
[TBL] [Abstract][Full Text] [Related]
20. Role for alpha-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies.
Grady RM; Grange RW; Lau KS; Maimone MM; Nichol MC; Stull JT; Sanes JR
Nat Cell Biol; 1999 Aug; 1(4):215-20. PubMed ID: 10559919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
